|
1
|
Martin GS: Sepsis, severe sepsis and
septic shock: Changes in incidence, pathogens and outcomes. Expert
Rev Anti Infect Ther. 10:701–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Angus DC and van der Poll T: Severe sepsis
and septic shock. N Engl J Med. 369:840–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dellinger RP, Levy MM, Rhodes A, Annane D,
Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke
R, et al: Surviving sepsis campaign: International guidelines for
management of severe sepsis and septic shock, 2012. Intens Care
Med. 39:165–228. 2013. View Article : Google Scholar
|
|
4
|
Levy MM, Fink MP, Marshall JC, Abraham E,
Angus D, Cook D, Cohen J, Opal SM, Vincent JL and Ramsay G:
SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International
Sepsis Definitions onference. Crit Care Med. 31:1250–1256. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaukonen KM, Bailey M, Suzuki S, Pilcher D
and Bellomo R: Mortality related to severe sepsis and septic shock
among critically ill patients in Australia and New Zealand,
2000–2012. JAMA. 311:1308–1316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernard GR, Vincent JL, Laterre PF, LaRosa
SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE,
Helterbrand JD, Ely EW, et al: Efficacy and safety of recombinant
human activated protein C for severe sepsis. N Engl J Med.
344:699–709. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rivers E, Nguyen B, Havstad S, Ressler J,
Muzzin A, Knoblich B, Peterson E and Tomlanovich M: Early
Goal-Directed Therapy Collaborative Group: Early goal-directed
therapy in the treatment of severe sepsis and septic shock. N Engl
J Med. 345:1368–1377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peake SL, Bailey M, Bellomo R, Cameron PA,
Cross A, Delaney A, Finfer S, Higgins A, Jones DA, Myburgh JA, et
al: Australasian resuscitation of sepsis evaluation (ARISE): A
multi-centre, prospective, inception cohort study. Resuscitation.
80:811–818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wawrzeniak IC, Loss SH, Moraes MC, De La
Vega FL and Victorino JA: Could a protocol based on early
goal-directed therapy improve outcomes in patients with severe
sepsis and septic shock in the intensive care unit setting? Indian
J Crit Care Med. 19:159–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Li X and Wang Z: Antioxidant
activities of leaf extract of Salvia miltiorrhiza Bunge and related
phenolic constituents. Food Chem Toxicol. 48:2656–2662. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Son B, Jun SY, Seo H, Youn H, Yang HJ, Kim
W, Kim HK, Kang C and Youn B: Inhibitory effect of traditional
oriental medicine-derived monoamine oxidase B inhibitor on
radioresistance of non-small cell lung cancer. Sci Rep.
6:219862016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guan Y, Wu XX, Duan JL, Yin Y, Guo C, Wei
G, Wang YH, Zhu YR, Weng Y, Xi MM and Wen AD: Effects and mechanism
of combination of rhein and danshensu in the treatment of chronic
kidney disease. Am J Chin Med. 43:1381–1400. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Wang L, Akinyi M, Li Y, Duan Z, Zhu
Y and Fan G: Danshensu protects isolated heart against ischemia
reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.
Int J Clin Exp Med. 8:14793–14804. 2015.PubMed/NCBI
|
|
14
|
Yang Y, Su Y, Wang D, Chen Y, Wu T, Li G,
Sun X and Cui L: Tanshinol attenuates the deleterious effects of
oxidative stress on osteoblastic differentiation via Wnt/FoxO3a
signaling. Oxid Med Cell Longev. 2013:3518952013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu XH, Pan LL, Jia YL, Wu D, Xiong QH,
Wang Y and Zhu YZ: A novel compound DSC suppresses
lipopolysaccharide-induced inflammatory responses by inhibition of
Akt/NF-κB signalling in macrophages. Eur J Pharmacol. 708:8–13.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Wang L, Wu Y, Su D, Wang N, Wang
J, Shi C, Lv L and Zhang S: Tanshinol suppresses inflammatory
factors in a rat model of vascular dementia and protects
LPS-treated neurons via the MST1-FOXO3 signaling pathway. Brain
Res. 1646:304–314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shioji I: Oxidative stress related
diseases and biopyrrins. Rinsho Byori. 53:155–159. 2005.(In
Japanese). PubMed/NCBI
|
|
18
|
Kubota M, Hasegawa T, Nakakura T, Tanii H,
Suzuki M and Tanaka S: Molecular and cellular characterization of a
new aquaporin, AQP-x5, specifically expressed in the small granular
glands of Xenopus skin. J Exp Biol. 209:3199–3208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delporte C, Bryla A and Perret J:
Aquaporins in salivary glands: From basic research to clinical
applications. Int J Mol Sci. 17:pii: E166. 2016. View Article : Google Scholar
|
|
20
|
Verkman AS, Anderson MO and Papadopoulos
MC: Aquaporins: Important but elusive drug targets. Nat Rev Drug
Discov. 13:259–277. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen Y, Wang Y, Chen Z, Wang D, Wang X,
Jin M and Bai C: Role of aquaporin 5 in antigen-induced airway
inflammation and mucous hyperproduction in mice. J Cell Mol Med.
15:1355–1363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gresz V, Horvath A, Gera I, Nielsen S and
Zelles T: Immunolocalization of AQP5 in resting and stimulated
normal labial glands and in Sjögren's syndrome. Oral Dis.
21:e114–e120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin F, Pan LH, Ruan L, Qian W, Liang R, Ge
WY and Huang B: Differential expression of HIF-1α, AQP-1, and VEGF
under acute hypoxic conditions in the non-ventilated lung of a
one-lung ventilation rat model. Life Sci. 124:50–55. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han G, Ma L, Guo Y, Li L, Li D and Liu H:
Hyperbaric oxygen therapy palliates lipopolysaccharide-induced
acute lung injury in rats by upregulating AQP1 and AQP5 expression.
Exp Lung Res. 41:444–449. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang ZQ, Song YL, Chen ZH, Shen Y and Bai
CX: Deletion of aquaporin 5 aggravates acute lung injury induced by
Pseudomonas aeruginosa. J Trauma. 71:1305–1311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Direito I, Madeira A, Brito MA and Soveral
G: Aquaporin-5: From structure to function and dysfunction in
cancer. Cell Mol Life Sci. 73:1623–1640. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Govindan S, Iwashyna TJ, Odden A, Flanders
SA and Chopra V: Mobilization in severe sepsis: An integrative
review. J Hosp Med. 10:54–59. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen H, Xie K, Han H, Li Y, Liu L, Yang T
and Yu Y: Molecular hydrogen protects mice against polymicrobial
sepsis by ameliorating endothelial dysfunction via an Nrf2/HO-1
signaling pathway. Int Immunopharmacol. 28:643–654. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khatri M and Sharma JM: Infectious bursal
disease virus infection induces macrophage activation via p38 MAPK
and NF-kappaB pathways. Virus Res. 118:70–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rydkina E, Silverman DJ and Sahni SK:
Activation of p38 stress-activated protein kinase during Rickettsia
rickettsii infection of human endothelial cells: Role in the
induction of chemokine response. Cell Microbiol. 7:1519–1530. 2005.
View Article : Google Scholar : PubMed/NCBI
|
